Contract HHSN271201600137P
Enzo Life Sciences, Inc · Department Of Health And Human Services · February 22, 2016
Enzo Life Sciences, Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on February 22, 2016 for $7,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Rockville, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 7, 2020.
Contract details
- PIID
- HHSN271201600137P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Rockville, MD
- First action
- February 22, 2016
- Latest action
- April 7, 2020
Description
SMALL MOLECULE SYNTHESIS
Modification timeline
-
April 7, 2020Mod P00001$-83
-
February 22, 2016Base awardIGF::OT::IGF$7.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN271201600137P?
Contract HHSN271201600137P is a federal contract awarded to Enzo Life Sciences, Inc by Department Of Health And Human Services on February 22, 2016 for $7,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN271201600137P?
Enzo Life Sciences, Inc won contract HHSN271201600137P from Department Of Health And Human Services.
How much is contract HHSN271201600137P worth?
Contract HHSN271201600137P has obligated $7,000 to date.